Epidemiology of Haemophilus influenzae strains identified in 2001 in France, and assessment of their susceptibility to beta-lactams;Épidémiologie et évaluation de la sensibilité aux bêta-lactamines des souches de Haemophilus influenzae isolées en 2001 en France

Medecine et Maladies Infectieuses

Volumn 34, Issue 2, 2004, Pages 97-101

  Dabernat, H ^a   Seguy, M ^a   Faucon, G ^a   Delmas, C ^a  

^a Laboratoire de Microbiologie   (France)

Author keywords

Haemophilus influenzae; Resistance to antibiotics; lactams

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFACLOR; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CEPHALOSPORIN; NITROCEFIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; BRONCHUS SECRETION; CONJUNCTIVITIS; DILUTION; ENZYME SYNTHESIS; FRANCE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OTITIS MEDIA; SEROTYPING; STRAIN DIFFERENCE; BACTERIAL COUNT; BACTERIAL INFECTION; CLASSIFICATION; DEMOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; PATHOGENICITY;

COLONY COUNT, MICROBIAL; DEMOGRAPHY; DRUG RESISTANCE, BACTERIAL; FRANCE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; SEROTYPING;

EID: 0842326522     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2003.10.005     Document Type: Article

References (22)

1. Dabernat H., Stahl J.P., Goulet V. Méningites bactériennes en France. Étude dans six départements métropolitains en 1995-1997. Méd Mal Infect. 30:2000;588-594.
2. Dabernat H., Delmas C. Activité du Centre national de référence pour Haemophilus influenzae, bilan 1994-1995. Les débuts de l'après vaccination. Méd Mal Infect. 26:1996;698-703.
3. Dabernat H. Haemophilus influenzae et antibiotiques. Freney T., Renaud F., Hansen W., Bollet C. Précis de bactériologie clinique. 2000;706-708. Éditions ESKA.
4. Dabernat H. Haemophilus influenzae. (Centre national de référence des Haemophilus influenzae). Surveillance nationale des maladies infectieuses 1998-2000. 2003;91-95 Institut de veille- sanitaire, Saint-Maurice.
5. Dabernat H., Seguy M., Delmas C. Activité de neuf ß-lactamines sur 280 souches d'Haemophilus influenzae résistantes à l'ampicilline par bêta-lactamase et mécanisme non enzymatique. Méd Mal Infect. 32:2002;299-306.
6. Falla T.J., Crook D.W.M., Brophy N., Maskell D., Kroll J.S., Moxon E.R. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol. 32:1994;2382-2386.
7. Tenover F.C., Huang M.B., Rasheed J., Persin D.H. Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. J Clin Microbiol. 32:1994;2729-2737.
8. Comité de l'antibiogramme de la Société française de microbiologie: communiqué 2002. 2002. URL: http//www.sfm.asso.org.
9. Drugeon H.B., Juvin M.E., Bensalah A., Moniot-Ville N. Sensibilité des trois principaux pathogènes respiratoires aux bêta-lactamines en France en 2000-2001: résultats d'une étude multicentrique. Antibiotiques. 4:2002;193-196.
10. Dabernat H., Seguy M., Delmas C. Activité in vitro du cefpodoxime et de sept autres bêta-lactamines vis-à-vis de 134 souches d'Haemophilus influenzae de phénotypes de résistance variés isolées d'otites et d'autres infections en 1996. Méd Mal Infect. 28:1998;438-441.
11. Biedenbach D.J., Jones R.N., Pfaller M.A. Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States. Diagn Microbiol Infect Dis. 39:2001;245-250.
12. Hoban D., Waites K., Felmingham D. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study. Diagn Microbiol Infect Dis. 45:2003;251-259.
13. Verhoef J., Gillissen A. Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role of cefixime. Inter J Antimicrob Agents. 21:2003;501-509.
14. Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., Pasquier C. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother. 46:2002;2208-2218.
15. Seki H., Kasahara Y., Ohta K., Saikawa Y., Sumita R., Yachie A., et al. Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy. 45:1999;15-21.
16. Doern G.V., Jones R.N., Pfaller M.A., Kugler K. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother. 43:1999;385-389.
17. Ubukata K., Shibasaki Y., Yamamoto K., Chiba N., Hasegawa K., Takeuchi Y., et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 2001;1693-1699.
18. Hasegawa K., Yamamoto K., Chiba N., Kobayashi R., Nagai K., Jacobs M.R., Appelbaum P.C., Sunakawa K., Ubukata K. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 9:2003;39-46.
19. Ohkusu K., Nakamura A., Sawada K. Antibiotic resistance among recent clinical isolates of Haemophilus influenzae in Japanese children. Diagn Microbiol Infect Dis. 36:2000;249-254.
20. Doern G.V., Brueggemann A.B., Pierce G., Holley H.P. Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicilline-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother. 41:1997;292-297.
21. Jacobs M.R., Bajaksouzian S. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicilline-clavulanic acid. Diagn Microbiol Infect Dis. 28:1997;105-112.
22. Gazagne L., Delmas C., Bingen E., Dabernat H. Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae. J Clin Microbiol. 36:1998;3629-3635.